Nortriptyline, developed by Geigy, first appeared in scientific literature in 1962 and was patented the same year before being officially introduced in 1963 for the treatment of depression. It is a secondary amine tricyclic antidepressant and functions as a metabolite of Amitriptyline. Primarily indicated for endogenous depression, it is also used in some cases to manage chronic pain, neuropathic pain, and to prevent headaches. Its mechanism of action involves increasing the synaptic levels of norepinephrine and, to a lesser extent, serotonin in the central nervous system by inhibiting their reuptake. Nortriptyline was among the first drugs identified to be metabolized by the CYP2D6 enzyme.
BRAND NAMES
The most common brand name for nortriptyline is Pamelor. It is also known by the brand name Aventyl (or Aventyl Hydrochloride). While often referred to by these names, it is widely available as generic nortriptyline in capsule and oral solution forms.
Other international or less common brand names include:
Allegron
Noritren
Norpress
Sensival
Nortrilen
MECHANISM OF ACTION
Nortriptyline works by inhibiting the reuptake of the neurotransmitters norepinephrine and, to a lesser extent, serotonin in the central nervous system. By blocking their reabsorption into nerve cells, it increases their availability in the synaptic cleft, which helps improve mood and modulate pain signals. As a tricyclic antidepressant and an active metabolite of Amitriptyline, it also has mild effects on other receptors, such as histamine and acetylcholine receptors, which contribute to both its therapeutic actions and side effects.
PHARMACOKINETICS
Absorption: Nortriptyline is readily absorbed, though plasma levels can vary significantly between individuals.
Distribution: It is widely distributed throughout the body, reaching tissues such as the heart, lungs, brain, and liver.
Metabolism: It undergoes hepatic metabolism through demethylation and hydroxylation, mainly involving enzymes like CYP2D6 enzyme, CYP1A2 enzyme, CYP2C19 enzyme, and CYP3A4 enzyme. Its metabolite, 10-hydroxynortriptyline, is pharmacologically active.
Elimination: It is mainly excreted through urine, with only about 2% eliminated unchanged.
PHARMACODYNAMICS
Nortriptyline’s pharmacodynamics primarily involve modulation of neurotransmitter activity in the central nervous system. It acts by inhibiting the reuptake of norepinephrine and, to a lesser extent, serotonin, thereby increasing their availability at synaptic junctions and enhancing neurotransmission. This contributes to its antidepressant and analgesic effects. As a tricyclic antidepressant and active metabolite of Amitriptyline, nortriptyline also exhibits affinity for other receptors, including histamine (H1), muscarinic cholinergic, and alpha-1 adrenergic receptors. These additional receptor interactions are responsible for many of its side effects, such as sedation, dry mouth, and orthostatic hypotension, while also contributing to its overall therapeutic profile.
ADMINISTRATION
Nortriptyline is administered orally in the form of capsules or an oral solution and can be taken with or without food. The dose is usually started low and adjusted gradually based on response, and it may be given in divided doses or as a single dose at bedtime to reduce daytime drowsiness. Consistent daily intake at the same time is recommended, and treatment should not be stopped abruptly but tapered gradually under medical supervision.
DOSAGE AND STRENGTH
Available Forms: Nortriptyline is available as capsules and an oral solution.
Strengths: Capsules come in 10 mg, 25 mg, 50 mg, and 75 mg; oral solution is typically 10 mg per 5 mL.
Starting Dose: Usually initiated at a low dose, around 25 mg once to three times daily.
Dose Adjustment: Gradually increased based on patient response and tolerability.
Maximum Dose: Generally up to 150 mg per day.
Dosing Schedule: May be given in divided doses or as a single dose at bedtime to reduce sedation.
FOOD INTERACTIONS
Nortriptyline may be taken with or without food, although taking it with meals can help reduce the chance of stomach upset. Alcohol should be avoided, as it can enhance drowsiness, dizziness, and overall impairment. Grapefruit juice may increase drug levels in the body, while excessive caffeine intake can potentially increase heart rate and restlessness.
DRUG INTERACTIONS
Nortriptyline can interact significantly with monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), and other central nervous system (CNS) depressants, potentially causing serious effects such as serotonin syndrome, severe high blood pressure, or excessive sedation. Alcohol should also be avoided, and it is important to inform healthcare providers about all prescription drugs, over-the-counter medications, and supplements, as there are many possible drug interactions.
CONTRAINDICATIONS
Nortriptyline should not be used in individuals with a known allergy to the drug. It is also contraindicated during the acute recovery period following a myocardial infarction and when taken with monoamine oxidase inhibitors (MAOIs), as this combination can lead to life-threatening reactions. Concurrent use with linezolid or intravenous methylene blue is also contraindicated. Additionally, it should be avoided in patients with Brugada syndrome, severe liver impairment, or active manic episodes.
SIDE EFFECTS
Common side effects:
Dry mouth
Drowsiness or sedation
Dizziness
Constipation
Blurred vision
Increased sweating
Weight gain
Cardiovascular effects:
Fast heart rate (tachycardia)
Low blood pressure (especially on standing)
Palpitations
Central nervous system effects:
Confusion (more common in older adults)
Restlessness or agitation
Headache
Anticholinergic effects:
Difficulty urinating
Dry eyes
Memory impairment
Serious but rare effects:
Heart rhythm disturbances (arrhythmias)
Seizures
Severe mood changes or suicidal thoughts (especially in young patients)
TOXICITY
Nortriptyline toxicity is a serious and potentially life-threatening condition that occurs due to overdose of this tricyclic antidepressant. It mainly leads to cardiotoxic effects such as arrhythmias and QRS complex widening, along with severe central nervous system depression, including seizures and coma. Ingesting doses greater than 5 mg/kg, and especially 10–20 mg/kg, can result in severe poisoning or fatal outcomes, requiring urgent medical treatment.